Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's

Two of the biggest listings in market history are queued up for the back end of this year, and punte

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) said on Tuesday it has taken decisive action followin

Lisata has filed suit in the Delaware Court of Chancery against Kuva over Kuva’s breach of the previ

Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market

Lisata Therapeutics stock fell after hours after updating investors on its pending acquisition and t

Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re

Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Lisata Therapeuti

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 15, 2026) - Law office of Brodsky & Smith announce

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs

Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent

Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs

Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and

NEW YORK--(BUSINESS WIRE)--LSTA, the trade association for the U.S. corporate lending market, today

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE), a clinical-stage pharmaceutical company developing t

MILWAUKEE, March 9, 2026 /PRNewswire/ -- Ademi LLP is investigating Lisata (NASDAQ: LSTA) for possib

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE), a clinical-stage pharmaceutical company developing t

Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr

Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr

Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent va

Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent va

Lisata Therapeutics (NASDAQ: LSTA - Get Free Report) will likely be issuing its Q4 2025 results befo

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-sta

Lisata Therapeutics shares surged premarket after Kuva Labs agreed to acquire the company for $4 per

Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be

Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.49) per share which beat the anal

Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stag

Results to be presented at the AACR Special Conference in Cancer Research: Advances in Pancreatic Ca

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:LSTA) wit

Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.54) per share which beat the anal